Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

UBS Sticks to Their Buy Rating for Xylem (XYL)

Tipranks - Tipranks - Sat Feb 14, 8:50AM CST

In a report released today, Joshua Spector from UBS maintained a Buy rating on Xylem, with a price target of $155.00.

Valentine's Day Sale - 70% Off

According to TipRanks, Spector is a 4-star analyst with an average return of 4.6% and a 56.85% success rate. Spector covers the Basic Materials sector, focusing on stocks such as Axalta Coating Systems, Linde, and Ecolab.

In addition to UBS, Xylem also received a Buy from Oppenheimer’s Bryan Blair in a report issued yesterday. However, on February 11, Mizuho Securities maintained a Hold rating on Xylem (NYSE: XYL).

See Insiders’ Hot Stocks on TipRanks >>

Based on Xylem’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $2.4 billion and a net profit of $335 million. In comparison, last year the company earned a revenue of $2.26 billion and had a net profit of $326 million

Read More on XYL:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).